- VRTX +0.71%
Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
Yahoo Finance · 1 week ago
Search results
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
- 491.57Add to watchlist+3.45 (+0.71%)At close: Fri. Jul 19, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open490.73High495.79Low489.11
- Mkt Cap126.85BP/E (TTM)31.94Div & YieldN/A & N/A
- Prev. Close488.1252 Wk. Low340.2052 Wk. High496.93
What analysts are sayingTop storiesRelated stocks
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission, values and recognition.
Dec 8, 2023 · Vertex leads global development, manufacturing and commercialization of CASGEVY with support from CRISPR Therapeutics. In conjunction with the FDA approval of CASGEVY, Vertex will make a $200 million milestone payment to CRISPR, which will be capitalized and amortized to cost of sales.
Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions. Read More.
4 days ago · The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
